반응식
[NH2:1][C:2](=[O:37])[C@@H:3]([NH:20][C:21]([C:23]1([NH:29][C:30](=[O:36])[O:31][C:32]([CH3:35])([CH3:34])[CH3:33])[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1)=[O:22])[CH2:4][C:5]1[CH:10]=[CH:9][C:8](B2OC(C)(C)C(C)(C)O2)=[CH:7][CH:6]=1.Br[C:39]1[CH:44]=[CH:43][C:42]([S:45]([N:48]2[CH2:53][CH2:52][O:51][CH2:50][CH2:49]2)(=[O:47])=[O:46])=[CH:41][CH:40]=1.C(=O)([O-])[O-].[Na+].[Na+]>C(#N)C>[NH2:1][C:2](=[O:37])[C@@H:3]([NH:20][C:21]([C:23]1([NH:29][C:30](=[O:36])[O:31][C:32]([CH3:33])([CH3:35])[CH3:34])[CH2:24][CH2:25][O:26][CH2:27][CH2:28]1)=[O:22])[CH2:4][C:5]1[CH:10]=[CH:9][C:8]([C:39]2[CH:44]=[CH:43][C:42]([S:45]([N:48]3[CH2:53][CH2:52][O:51][CH2:50][CH2:49]3)(=[O:47])=[O:46])=[CH:41][CH:40]=2)=[CH:7][CH:6]=1참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
반응 조건
- 온도
- 85 °C
실험 절차
(S)-tert-Butyl 4-(1-amino-1-oxo-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (Example 16, step (i), 250 mg) in acetonitrile (8 mL) with 4-(4-bromophenylsulfonyl)morpholine (148 mg) was treated with aqueous sodium carbonate (2M, 0.5 mL) and nitrogen was bubbled through the mixture. 1,1 bis(Di-tert-butylphosphino)ferrocene palladium dichloride (5 mg) was added and the mixture was heated at 85° C. for 18 h under nitrogen. The reaction mixture was evaporated onto silica and purified by chromatography on silica eluting with ethyl acetate/isohexane (50:50 to 100:0) to afford the sub-titled compound (240 mg).
후처리
- customwas bubbled through the mixture
- addition1,1 bis(Di-tert-butylphosphino)ferrocene palladium dichloride (5 mg) was added
- customThe reaction mixture was evaporated onto silica
- custompurified by chromatography on silica eluting with ethyl acetate/isohexane (50:50 to 100:0)
출처 및 근거
- ORD 기록
- ord-1a89f85327c742928b7a8c64219f76c9
- 출처 데이터셋
- uspto-grants-2012_06
- 특허 번호
- US08193239B2
연결된 노트
불러오는 중…